Investigative Ophthalmology & Visual Science Cover Image for Volume 62, Issue 8
June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Lacritin Proteoform Rescue of Epithelial Corneal Homeostasis Requires GPR87 Coupled to Syndecan-1
Author Affiliations & Notes
  • Karina Luiza Dias Teixeira
    Cell Biology, University of Virginia, Charlottesville, Virginia, United States
  • Jeff Romano
    Cell Biology, University of Virginia, Charlottesville, Virginia, United States
  • Gordon W Laurie
    Cell Biology, University of Virginia, Charlottesville, Virginia, United States
    Biomedical Engineering, University of Virginia, Charlottesville, Virginia, United States
  • Footnotes
    Commercial Relationships   Karina Luiza Dias Teixeira, None; Jeff Romano, None; Gordon Laurie, TearSolutions Inc. (F), UVa Licensing and Ventures Group (P)
  • Footnotes
    Support  EY024327, EY026171, UVA Pinn Scholar Award, and an unrestricted gift from TearSolutions, Inc,
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 1313. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Karina Luiza Dias Teixeira, Jeff Romano, Gordon W Laurie; Lacritin Proteoform Rescue of Epithelial Corneal Homeostasis Requires GPR87 Coupled to Syndecan-1. Invest. Ophthalmol. Vis. Sci. 2021;62(8):1313.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Dry eye disease affects 7 - 10% of people worldwide. Dry eye is characterized by chronic inflammation and damage of the ocular surface. Lacritin (and several of its C-terminal proteoforms) is a prosecretory growth factor in tears that, based on preclinical and cell culture studies, restores basal tearing and ocular surface health. We previously reported on identification of cornea expressed G protein-coupled receptor 87 (GPR87) as a lacritin signaling receptor out of a genome-wide CRISPR/Cas9 screen. Here we sought to validate this observation, and ask whether GPR87 couples with lacritin co-receptor syndecan-1 (SDC1).

Methods : Validation studies of GPR87 were performed by generation of GPR87 knockout cell lines by CRISPR/Cas9 editing and by shRNA depletion of transduced human corneal epithelial (HCE-T) cells with lentiviral GPR87 sgRNA or shRNA and non-target controls. Depletion of GPR87 protein level was confirmed by western blotting. Complementation assays were performed by transducing depleted HCE-T’s with lentiviral GPR87 cDNA obtained from DNASU Plasmid Repository. To explore whether GPR87 can couple with SDC1, we blotted for GPR87 out of SDC-1 pulldowns from HEK2936E cells co-transfected with wild type or mutated GPR87 and SDC1 cDNA’s. GPR87- lacritin binding was studied out of recombinant lacritin- or C-25-intein pulldowns. ‘C-25’, lacks lacritin's 'N-94' bioactive domain. N-94 is a synthetic peptide analogous to several lacritin C-terminal proteoforms naturally in tears.

Results : Depletion of GPR87 abrogated N-94 rescue of IFNG/TNF stressed HCE-T’s, but was rescued by complementation with GPR87 cDNA. GPR87 complexes with SDC1 in the absence of N-94, but not with SDC1 lacking the PDZ binding domain nor lacking N-terminal domain heparan sulfate at S15 nor membrane proximal chondroitin sulfate at S184 and S185. SDC1 failed to bind GPR87 lacking the G-protein binding site “DRY” motif. Lacritin, but not C-25, binds GPR87.

Conclusions : N-94 targets a preformed SDC1-GPR87 complex, the latter linked in part by glycosaminoglycans, and apparently by cytoplasmic SDC1 and GPR87 domains to regulate ocular surface health.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×